We are an end-to-end biotech developing transformational medicines, with technology at our core. Our ambition is to understand human biology in an unprecedented way; discovering therapies that will treat some of life's most devastating diseases. We leverage single-cell multi-omics directly from patient tissue, functional assays and machine learning to drive at disease understanding — from cause to cure.
Our interdisciplinary approach brings together the best from techbio, pharma, academia and venture — all working towards one common goal.
Relation is led by experienced drug developers, computational scientists and entrepreneurs with experience across biotech, pharma, venture and academic research. We have a hunger to transform drug development as we know it — because the patient is waiting.